JW Pharmaceutical Corporation (001067.KS) KSC

61,100.00

+300(+0.49%)

Updated at December 24 03:30PM

Currency In KRW

Valuation

Market Cap559.8B
Enterprise Value641.1B
P/E Ratio10.32
PEG Ratio0.47
Price/Sales Ratio0.81
Price/Book Ratio1.83
Enterprise/Revenue0.86
Enterprise/EBITDA3.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.13

Management Effectiveness

Return On Assets0.1
Return On Equity0.19

Income Statement

Revenue719.38B
Revenue/Share31,654.73
Gross Profit323.5B
EBITDA110.17B
Net Income65.04B
Diluted EPS2,644.47

Balance Sheet

Total Cash82.51B
Total Cash/Share3,417.81
Total Debt68.66B
Total Debt/Equity0.19
Current Ratio1.51
Book Value Per Share14,667.38

Price History

52-Week Change-1.77
52-Week High65,600
52-Week Low56,100
Moving Average 50 Days60,496
Moving Average 200 Days61,208.5

Statistics

Average Volume64
Shares Outstanding9.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate450
Trailing Annual Dividend Yield1.68
Payout Ratio0.18
Last Split Factor51:50
Last Split DateDecember 27, 2023